公开(公告)号：US11813393B2

公开(公告)日：2023-11-14

申请号：US17536856

申请日：2021-11-29

Applicant: KCI Licensing, Inc.

Inventor： Christopher Brian Locke ,  Aidan Marcus Tout

IPC: A61M1/00

CPC classification number: A61M1/602 ,  A61M1/882 ,  A61M1/90 ,  A61M1/98

Abstract: A wound fluid collection system includes a canister with a chamber fluidly connected to a wound dressing in a tissue site through an inlet and also fluidly connected to a reduced pressure source through an outlet. At least a portion of the canister is collapsible and yet can be maintained in an extended state when exposed to subatmospheric pressure. The canister is releasably attachable to a supporting member.

公开(公告)号：US11813392B2

公开(公告)日：2023-11-14

申请号：US16128252

申请日：2018-09-11

Applicant: KCI Licensing, Inc.

Inventor： Christopher Brian Locke ,  Richard Daniel John Coulthard ,  James A. Luckemeyer ,  Richard Marvin Kazala, Jr. ,  Benjamin Andrew Pratt ,  Timothy Mark Robinson

IPC: A61M1/00 ,  A61M27/00 ,  A61F13/00

CPC classification number: A61M1/602 ,  A61M1/74 ,  A61M1/743 ,  A61M1/918 ,  A61M1/96 ,  A61M1/98 ,  A61F13/00068 ,  A61F2013/0054 ,  A61F2013/00536 ,  A61M1/67 ,  A61M1/73 ,  A61M1/732 ,  A61M1/985 ,  A61M27/00 ,  A61M2205/15 ,  A61M2205/18 ,  A61M2205/21 ,  A61M2205/3344 ,  A61M2205/584 ,  A61M2205/84

Abstract: Systems and methods for treating a plurality of tissue sites include a multi-port therapy unit. The multi-port therapy unit includes a plurality of patient-side ports each fluidly coupled to a plurality of conduits and a fluid reservoir fluidly coupled to the plurality of ports. A plurality of pressure sensors are associated with the plurality of patient-side ports to determining a pressure associated with each conduit. A controller is operatively coupled to the plurality of pressure sensors to receive treatment pressure data, monitor pressure for each pressure sensor of the plurality of pressure sensors, and signal an alarm condition if the pressure is outside of a pre-selected range. The system includes a reduced-pressure source fluidly coupled to a dressing at each tissue site through the multi-port therapy unit.

公开(公告)号：US11806216B2

公开(公告)日：2023-11-07

申请号：US17259251

申请日：2019-07-08

Applicant: KCI Licensing, Inc.

Inventor： Christopher Brian Locke ,  Justin Alexander Long

IPC: A61M1/00 ,  A61M39/10 ,  A61M39/24 ,  A61F13/00 ,  A61M3/02

CPC classification number: A61F13/00068 ,  A61M1/92 ,  A61M3/0254 ,  A61M39/10 ,  A61M39/24 ,  A61M2205/3331 ,  A61M2205/3389 ,  A61M2205/3569

Abstract: Systems, apparatuses, and methods for instilling fluid to a tissue site in a negative-pressure therapy environment are described, Illustrative embodiments may include a pneumatically-actuated instillation pump that can draw a solution from a solution source during a negative-pressure interval, and instill the solution to a dressing during a venting interval. In one example embodiment, a system for providing negative-pressure and instillation to a tissue site may comprise a negative-pressure device and an instillation device. The negative-pressure device may comprise a negative-pressure source and a controller electrically coupled to the negative-pressure source. The instillation device may comprise a dosing valve having a dosing chamber including a dosing outlet configured to be fluidly coupled to a fluid port and a dosing inlet configured to be fluidly coupled to a source of instillation solution. The dosing valve may also have a working chamber including a biasing element operably engaged to the dosing chamber and configured to be fluidly coupled to the negative-pressure source. In some embodiments of the system, the instillation device may further comprise a wireless transceiver configured to communicate with the controller, and at least one sensor coupled to the wireless transceiver to provide a signal indicative of an operating condition of the dosing valve, and wherein the wireless transceiver is configured to communicate the at least one signal to the controller.

公开(公告)号：US11771816B2

公开(公告)日：2023-10-03

申请号：US16141239

申请日：2018-09-25

Applicant: KCI Licensing, Inc.

Inventor： Christopher Brian Locke ,  James A. Luckemeyer ,  Timothy Mark Robinson

IPC: A61M37/00 ,  A61M3/02 ,  A61F13/00 ,  A61M1/00

CPC classification number: A61M1/74 ,  A61M1/77 ,  A61M1/85 ,  A61M1/92 ,  A61M3/0201 ,  A61M3/0202 ,  A61M3/022 ,  A61M3/0254 ,  A61M37/00 ,  A61F13/00068 ,  A61M1/743 ,  A61M1/96 ,  A61M1/982 ,  A61M2205/123 ,  A61M2205/128 ,  A61M2205/3334 ,  A61M2205/3337 ,  A61M2205/3382 ,  A61M2205/50

Abstract: A fluid delivery system, method, and apparatus for providing instillation therapy with a negative-pressure source is described. The apparatus includes a housing having an ambient chamber and a negative-pressure chamber fluidly isolated from each other. The apparatus also includes a moveable barrier disposed in the housing between the ambient chamber and the negative-pressure chamber. The moveable barrier is operable to move between a charge position and a discharge position in response to negative pressure. A fluid source is disposed in the negative-pressure chamber and is collapsible in response to movement of the moveable barrier to the discharge position. The apparatus also includes a fluid outlet in fluid communication with the fluid source, a negative-pressure port in fluid communication with the negative-pressure chamber and configured to be coupled to a negative-pressure source, and a vent formed in the housing and fluidly coupled to the ambient chamber.

公开(公告)号：US11771599B2

公开(公告)日：2023-10-03

申请号：US16759935

申请日：2018-10-22

Applicant: KCI Licensing, Inc.

Inventor： Christopher Brian Locke ,  Kristine M. Kieswetter ,  Timothy Mark Robinson

IPC: A61F13/00 ,  A61L15/22 ,  A61L15/26 ,  A61L15/42 ,  A61L15/44 ,  A61L15/62 ,  A61L15/64 ,  A61M1/00

CPC classification number: A61F13/00068 ,  A61F13/00012 ,  A61L15/225 ,  A61L15/26 ,  A61L15/425 ,  A61L15/44 ,  A61L15/62 ,  A61L15/64 ,  A61M1/90

Abstract: As an example, in some embodiments is a dressing that may comprise a manifold, a bioresorbable component, and a degradation-modulating component. The degradation-modulating component may cover two or more surfaces of the bioresorbable component. The degradation-modulating component may be further configured to modulate degradation of the bioresorbable component.

公开(公告)号：US11744740B2

公开(公告)日：2023-09-05

申请号：US17122855

申请日：2020-12-15

Applicant: KCI Licensing, Inc.

Inventor： Christopher Brian Locke

IPC: A61F13/00 ,  A61F13/02 ,  A61M1/00

CPC classification number: A61F13/00063 ,  A61F13/00068 ,  A61F13/0206 ,  A61F13/0216 ,  A61F13/0223 ,  A61M1/86 ,  A61M1/90 ,  A61F2013/0028 ,  A61F2013/00323

Abstract: A dressing for treating a tissue site may include a base layer, a sealing member, a first and a second wicking layer, and an absorbent layer. The base layer may have a periphery surrounding a central portion and a plurality of apertures disposed through the periphery and the central portion. At least one of the apertures in the periphery may be positioned at an edge of the periphery, and may have an interior exposed at the edge. The sealing member and the base layer may define an enclosure. The first and the second wicking layer may each be disposed in the enclosure with the absorbent layer positioned between the first and the second wicking layer. Other dressings, systems, and methods are disclosed.

公开(公告)号：US11730457B2

公开(公告)日：2023-08-22

申请号：US16325124

申请日：2017-08-10

Applicant: KCI Licensing, Inc.

Inventor： Christopher Brian Locke ,  Justin Alexander Long ,  Timothy Mark Robinson

IPC: A61B10/00 ,  A61F13/00 ,  A61M1/00

CPC classification number: A61B10/0045 ,  A61F13/00068 ,  A61M1/95 ,  A61B2010/0006 ,  A61M1/92 ,  A61M2205/584

Abstract: A sampling interface may comprise an inlet port, an outlet port, and a sampling chamber between the inlet port and the outlet port. The apparatus may also comprise a sampling port and at least one split seal between the sampling port and the sampling chamber. The split seal may comprise a first sealing member and a second sealing member that converge to a sealing line. The apparatus may additionally include at least one fluid collection channel disposed interior to the split seal. A lateral flow strip for sampling fluid removed from a tissue site may comprise an acquisition surface and a migration medium fluidly coupled to the acquisition surface. At least one test medium may be fluidly coupled to the migration medium, and a liquid-impermeable cover may enclose the migration medium and the test medium. The acquisition surface is preferably not enclosed.

公开(公告)号：US11565033B2

公开(公告)日：2023-01-31

申请号：US16595763

申请日：2019-10-08

Applicant: KCI Licensing, Inc.

Inventor： Christopher Brian Locke ,  Timothy Mark Robinson

IPC: A61M35/00 ,  A61M1/00 ,  A61F13/00 ,  A61B17/3203 ,  A61B17/32 ,  A61M3/02 ,  A61M3/00 ,  A61M31/00 ,  A61F13/02 ,  A61B17/22 ,  A61L2/10

Abstract: A treatment system for debriding a treatment area of a tissue site and applying negative pressure is disclosed. In some embodiments, the treatment system may include an ultrasonic bubble generator fluidly coupled to a negative-pressure source, fluid source, and a dressing. Fluid may be drawn from the fluid source to the ultrasonic bubble generator, whereby micro-bubbles and ultrasonic waves may be generated in the fluid before the fluid is instilled to the dressing.

公开(公告)号：US11471584B2

公开(公告)日：2022-10-18

申请号：US15997809

申请日：2018-06-05

Applicant: KCI Licensing, Inc.

Inventor： Christopher Brian Locke ,  Timothy Mark Robinson

IPC: A61M1/00 ,  A61F13/00 ,  A61F13/02

Abstract: Dressings for treating a tissue site with negative pressure are disclosed, which may include a dressing having at least three layers assembled in a stacked relationship. In one example embodiment, a first film may comprise a non-porous material and a plurality of fluid restrictions. A first manifold layer may be adjacent to the first film and may comprise a second film of a transparent material having blisters and a manifold area. The first manifold layer may further comprise apertures configured to allow fluid transfer through the second film. A second manifold layer may be adjacent to the first manifold layer and may comprise foam having a contact area that is less than the manifold area of the first manifold layer.

公开(公告)号：US11452810B2

公开(公告)日：2022-09-27

申请号：US17292917

申请日：2019-11-11

Applicant: KCI LICENSING, INC.

Inventor： Timothy Mark Robinson ,  Christopher Brian Locke

IPC: A61M1/00

Abstract: This disclosure describes devices, systems, and methods related to a connector for a dressing, such as a dressing of a hyperbaric oxygen therapy system. An example of a connector includes a connector body configured to define at least a portion of a first channel. The connector also includes a viewing member coupled to the connector body. The connector further includes a deformable member positioned within the first channel. The deformable member is configured to deform based on a pressure associated with the deformable member and to provide a visual indication, via the viewing member, of the pressure.